On March 12, Health Canada provided an update on the cannabis supply and demand statistics in Canada. There are some concerns for cannabis investors on the dried cannabis front. First, we’ll discuss the demand side.
In the above chart, you can see the sales data for dried cannabis and cannabis oil for October 2018 to January 2019. The preliminary data published by Health Canada showed that the total dried cannabis sales in January 2019 slowed to 7,115 kilograms sequentially.
The dried cannabis sales and medical cannabis sales decreased. The medical cannabis sales fell ~0.89% month-over-month, while the non-medical sales for dried cannabis fell 4.5% and contributed the most to the total decline.
In contrast, the total sales for cannabis oil rose 4% sequentially to 7,856 liters in January from 7,534 liters in December. Sequentially, the growth in oil sales from the medical side increased 1%, while the non-medical side rose 11% month-over-month. The oil sales from the non-medical side contributed the most to the gain. Companies (MJ) including Canopy Growth (WEED), Aurora Cannabis (ACB), Aphria (APHA), and Cronos Group (CRON) will eventually move to a more sophisticated form of cannabis from dried cannabis, which might cause dried cannabis sales to slow down.
The total unfinished inventory for dried cannabis rose to 114,628 kilograms from 110,729 kilograms. The finished inventory grew to 19,520 kilograms from 18,646 kilograms.
On the other hand, oil’s unfinished inventory grew to 26,782 liters from 26,756 liters. The finished inventory grew to 52,921 liters from 41,986 liters.